Desjardins, A., Reardon, D. A., Peters, K. B., Herndon, J., Kirkpatrick, J., Gururangan, S., … Vredenburgh, J. J. (2009). BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIAL. In NEURO-ONCOLOGY (Vol. 11, pp. 634–634).

Desjardins, Annick, David A. Reardon, Katherine B. Peters, James Herndon, John Kirkpatrick, Sridharan Gururangan, John H. Sampson, Allan H. Friedman, Henry Friedman, and James J. Vredenburgh. “BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIAL.” In NEURO-ONCOLOGY, 11:634–634, 2009.

Desjardins A, Reardon DA, Peters KB, Herndon J, Kirkpatrick J, Gururangan S, et al. BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIAL. In: NEURO-ONCOLOGY. 2009. p. 634–634.

Desjardins, Annick, et al. “BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIAL.” NEURO-ONCOLOGY, vol. 11, no. 5, 2009, pp. 634–634.

Desjardins A, Reardon DA, Peters KB, Herndon J, Kirkpatrick J, Gururangan S, Sampson JH, Friedman AH, Friedman H, Vredenburgh JJ. BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIAL. NEURO-ONCOLOGY. 2009. p. 634–634.